Optimised method for determination of ticlopidine in serum by high performance liquid chromatography. 1996

G Furlan, and N Malusà, and A Strohmayer, and F B Klugmann, and G Decorti, and L Candussio, and S Klugmann
Laboratorio di Tossicologia, Istituto di Medicina Legale e delle Assicurazioni, Ospedale Maggiore, Trieste.

In this study we verified whether high performance liquid chromatography with UV detection (HPLC-UV) could be optimised and hence become a useful method for measuring ticlopidine concentrations in patient blood. The extraction step was improved by adding isoamylic alcohol in the extraction mixture, resulting in a better recovery. Moreover, the extraction efficiency was consistently ameliorated by evaporation to dryness of the organic extract; we could therefore utilise a lower (213 nm) wavelength, corresponding to the maximum of absorption, achieving a better sensitivity. With these technical improvements, the limit of quantitation is 0.02 microgram/ml, and the limit of detection is 0.01 microgram/ml, hence comparable to levels obtained with gas-liquid chromatography with nitrogen detection (GC-NPD). In addition, HPLC method, if compared with GC-NPD, is simpler and can be easily used for routine determinations of a lot of serum samples.

UI MeSH Term Description Entries
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D002138 Calibration Determination, by measurement or comparison with a standard, of the correct value of each scale reading on a meter or other measuring instrument; or determination of the settings of a control device that correspond to particular values of voltage, current, frequency or other output. Calibrations
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013988 Ticlopidine An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES. 53-32C,Ticlid,Ticlodix,Ticlodone,Ticlopidine Hydrochloride,53 32C,5332C,Hydrochloride, Ticlopidine
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face

Related Publications

G Furlan, and N Malusà, and A Strohmayer, and F B Klugmann, and G Decorti, and L Candussio, and S Klugmann
December 1986, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
G Furlan, and N Malusà, and A Strohmayer, and F B Klugmann, and G Decorti, and L Candussio, and S Klugmann
March 1987, Chemical & pharmaceutical bulletin,
G Furlan, and N Malusà, and A Strohmayer, and F B Klugmann, and G Decorti, and L Candussio, and S Klugmann
June 1995, Therapeutic drug monitoring,
G Furlan, and N Malusà, and A Strohmayer, and F B Klugmann, and G Decorti, and L Candussio, and S Klugmann
November 1981, Nihon geka hokan. Archiv fur japanische Chirurgie,
G Furlan, and N Malusà, and A Strohmayer, and F B Klugmann, and G Decorti, and L Candussio, and S Klugmann
March 1979, Journal of chromatography,
G Furlan, and N Malusà, and A Strohmayer, and F B Klugmann, and G Decorti, and L Candussio, and S Klugmann
December 1988, The Kitasato archives of experimental medicine,
G Furlan, and N Malusà, and A Strohmayer, and F B Klugmann, and G Decorti, and L Candussio, and S Klugmann
July 1997, Se pu = Chinese journal of chromatography,
G Furlan, and N Malusà, and A Strohmayer, and F B Klugmann, and G Decorti, and L Candussio, and S Klugmann
October 1985, Journal of chromatography,
G Furlan, and N Malusà, and A Strohmayer, and F B Klugmann, and G Decorti, and L Candussio, and S Klugmann
May 1978, The Analyst,
G Furlan, and N Malusà, and A Strohmayer, and F B Klugmann, and G Decorti, and L Candussio, and S Klugmann
September 1987, Therapeutic drug monitoring,
Copied contents to your clipboard!